Navigation Links
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
Date:6/9/2009

Cardiatis SA, today announced that its Multilayer Aneurysm Repair System (MARS) has received CE Mark approval for treating patients with peripheral aneurysms. Product rollout is underway.

Brussels, Belgium (PRWEB) June 9, 2009 -- Cardiatis, SA announced today that it has received CE Mark approval for the commercial sale of its Multilayer Aneurysm Repair System.

The Multilayer Aneurysm Repair System (MARS) is based on non-invasive paradigm shifting technology that treats aneurysms, regardless of their location, endovasculary through hemodynamic flow modulation and parent artery repair techniques. The received CE Mark is for the peripheral indication and clinical development is underway for cerebral and thoraco-abdominal aortic aneurysm indications.

Due to novelty of the technology, Cardiatis has initiated limited rollout of the product to select interventional centers where physician training is underway.

"We are very pleased to provide physicians and patients with Cardiatis breakthrough Multilayer Aneurysm Repair System", said Noureddine Frid, Cardiatis president and chief executive officer. "Physicians will now have access to a new minimally-invasive technology that will allow them to treat peripheral aneurysms endovasculary while preserving precious collateral circulation."

The Multilayer Aneurysm Repair System (MARS) has proven to be highly deliverable and is effective in excluding aneurysms from circulation while preserving collaterals. It also offers an excellent safety profile, which is important to both physicians and patients.

More than 95% of peripheral artery aneurysms occur in males, and the average age of patients at presentation is 65 years. Atherosclerosis appears to be the etiology in more than 90% of cases. Popliteal artery aneurysms are the most common peripheral artery aneurysms accounting for up to 85% of total aneurysms in the periphery.

About Cardiatis

Cardiatis, an innovative medical technology company located in Belgium, is focused on developing and commercializing its patented Multilayer technology platform, a next generation technology for endovascular aneurysm repair. Additional information can be found on Cardiatis web site at www.cardiatis.com.

###

Read the full story at http://www.prweb.com/releases/Endovascular/Aneurysm/prweb2507714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Too Few Screened for Abdominal Aneurysm, Study Says
2. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
3. Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for Silent Killer, Abdominal Aortic Aneurysm
4. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
5. Aneurysms in 2nd Generation May Not Come Early
6. Routine testing after aneurysm coiling carries low risk
7. Brain Aneurysm Rupture Risk Tied to Location, Size
8. The Brain Aneurysm Foundation Announces 2008 Research Grant Recipients
9. NYC first: Complex aneurysm treated using new fenestrated endograft stent
10. Carnegie Mellon researchers improve assessments of aortic aneurysms
11. Women, Mexican-Americans at higher risk of ruptured brain aneurysm
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
(Date:5/23/2016)... ... 2016 , ... The Society for Women’s Health Research (SWHR) announced that its ... role. , “No one in Washington led the way to advance women’s health research ... MD, PhD. “We offer our deep gratitude to Phyllis for her passion and performance ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... on its Chesterfield, Missouri, campus, Standard Process Inc. awarded $6,000 in ... Siewert and Chloe Tillman. Each student is in her fifth trimester of classes ...
(Date:5/23/2016)... ... May 23, 2016 , ... Hadley ... worldwide for people who are blind or visually impaired, announces the election of ... President Charles E. Young. Hadley’s Board of Trustees retained Morris & Berger, a ...
(Date:5/23/2016)... ... May 23, 2016 , ... Four Circles Recovery Center, a leading treatment ... to announce the launch of its new extended care program, Fifth Circle. Available for ... Four Circles or another primary treatment program, Fifth Circle is designed to foster the ...
(Date:5/23/2016)... ... 23, 2016 , ... Bio-Optronics, Inc. is delighted to announce ... its recent and anticipated growth. , Max Elbaz was appointed as Vice President, ... segments. Max joined the Bio-Optronics team in March. His areas of expertise include ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... 19, 2016 BioLineRx Ltd. (NASDAQ/TASE: ... the treatment of multiple cancer and hematological indications, will ... An abstract titled " Clinical response in relapsed/refractory AML ... by BL-8040, a potent CXCR4 antagonist; results of a ... presentation at the European Hematology Association 21st Congress, to ...
(Date:5/19/2016)... and CAMBRIDGE, Massachusetts , May 19, ... in the development of pharmaceuticals and diagnostics based on the ... a new office in Cambridge, MA ... US. The office is located at Kendall Square, ... industry, well-known as the global hub for transforming scientific insights ...
(Date:5/18/2016)... May 19, 2016 ... Research Report initially provides a basic overview ... and manufacturing technology, post which the report ... in the market. Complete report ... pages providing 8 company profiles and 98 ...
Breaking Medicine Technology: